Rare Moulds
Global guideline for the diagnosis and management of rare mould infections: an initiative of ECMM in cooperation with ISHAM and ASM
The Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology was released on February 16, 2021.
This is the second guideline of the One World – One Guideline initiative intending to diagnose these devastating diseases earlier, and to lead to more rapid and targeted treatment initiation.
45 experts from 24 countries developed this guidance document. Upon today‘s publication in Lancet Infectious Diseases, the guideline was endorsed by 55 scientific societies from around the world.
Here is a link to the published article on The Lancet website: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30784-2/fulltext
Article citation:
Hoenigl, M., Salmanton-García, J., Walsh, T. J., Nucci, M., Neoh, C. F., Jenks, J. D., et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. The Lancet Infectious Diseases. 2021 doi:10.1016/S1473-3099(20)30784-2
For full texts click below:
Hoenigl TLID 2021 Global guideline for the diagnosis and management of rare mould infections
